*1.Please list your last name and zip code:(Required.)

Last name:

ZIP/Postal Code:

*2.What is your specialty?(Required.)

*3.How many patients with cholangiocarcinoma do you treat each week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

*4.What major electrolyte abnormalities are associated with FGFR inhibitors?(Required.)

Hypokalemia

Hyperphosphatemia

Hypophosphatemia

Hypocalcemia

*5.When should NGS be performed in metastatic/unresectable cholangiocarcinoma?(Required.)

At diagnosis

After progression on first-line therapy

No role for NGS